Cytotoxic effect of sanguiin H-6 on MCF-7 and MDA-MB-231 human breast carcinoma cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Eun-Ji | - |
dc.contributor.author | Lee, Dahae | - |
dc.contributor.author | Baek, Seon-Eun | - |
dc.contributor.author | Kim, Ki Hyun | - |
dc.contributor.author | Kang, Ki Sung | - |
dc.contributor.author | Jang, Tae Su | - |
dc.contributor.author | Lee, Hye Lim | - |
dc.contributor.author | Song, Ji Hoon | - |
dc.contributor.author | Yoo, Jeong-Eun | - |
dc.date.available | 2020-02-27T17:42:06Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-09-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5708 | - |
dc.description.abstract | Sanguiin H-6 is a dimer of casuarictin linked by a bond between the gallic acid residue and one of the hexahydroxydiphenic acid units. It is an effective compound extracted from Rubus coreanus. It has an anticancer effect against several human cancer cells; however, its effect on breast cancer cells has not been clearly demonstrated. Thus, we aimed to investigate the anticancer effect and mechanism of action of sanguiin H-6 against two human breast carcinoma cell lines (MCF-7 and MDA-MB-231). We found that sanguiin H-6 significantly reduced cell viability in a concentration-dependent manner. It also increased the rates at which MCF-7 and MDA-MB-231 cells underwent apoptosis. Furthermore, sanguiin H-6 induced the cleavage of caspase-8, caspase-3, and poly(ADP-ribose) polymerase, which resulted in apoptosis. However, cleavage of caspase-9 was only detectable in MCF-7 cells. In addition, sanguiin H-6 increased the ratio of Bax to Bcl-2 in both MCF-7 and MDA-MB-231 cells. These findings suggest that sanguiin H-6 is a potent therapeutic agent against breast cancer cells. In addition, it exerts its anticancer effect in an estrogen-receptor-independent manner. (C) 2017 Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.subject | APOPTOSIS | - |
dc.subject | MITOCHONDRIA | - |
dc.subject | COMPONENT | - |
dc.title | Cytotoxic effect of sanguiin H-6 on MCF-7 and MDA-MB-231 human breast carcinoma cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000410730200028 | - |
dc.identifier.doi | 10.1016/j.bmcl.2017.08.019 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.27, no.18, pp.4389 - 4392 | - |
dc.identifier.scopusid | 2-s2.0-85027992880 | - |
dc.citation.endPage | 4392 | - |
dc.citation.startPage | 4389 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 27 | - |
dc.citation.number | 18 | - |
dc.contributor.affiliatedAuthor | Kang, Ki Sung | - |
dc.contributor.affiliatedAuthor | Lee, Hye Lim | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Sanguiin H-6 | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Estrogen receptor | - |
dc.subject.keywordAuthor | MCF-7 cells | - |
dc.subject.keywordAuthor | MDA-MB-231 cells | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | MITOCHONDRIA | - |
dc.subject.keywordPlus | COMPONENT | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.